Study of the Chinese Prescription Weiqi Decoction on Chronic Atrophic Gastritis

Shanghai University of Traditional Chinese Medicine

Status: Completed

Conditions: Gastritis

Treatments: Drug: Weiqi decotion

Study type: Interventional

Funder types: Other

Identifiers

NCT00920712

SHTCM-001

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription Weiqi decoction on Chronic Atrophic Gastritis.

Enrollment: 200 patients

Sex: All

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Clinical diagnosis of Chronic Atrophic Gastritis
• Male of female patients between 18-65 years old
• Written informed consent

Exclusion criteria

• Combine with malignant pathology on epithelial dysplasia of gastric mucosa
• Combine with duodenal ulcer or gastric ulcer
• Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
• Pregnancy or breast feeding women, or unwilling to have contraception.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

200 participants in 2 patient groups, including a placebo group

Weiqi decoction

Experimental group

Treatment:

Drug: Weiqi decotion

low dose of Weiqi decoction

Placebo Comparator group

Treatment:

Drug: Weiqi decotion